Indian, Southeast Asia trio join bond glut

After a week of heavy bond supply from Hong Kong and Chinese credits, Jubilant Pharma, Kasikornbank and RHB Bank added some variety — and all got a strong welcome.

Indian generic drug maker Jubilant Pharma, Malaysian lender RHB Bank and Thailand’s Kasikornbank turned to the debt markets near the end of the week, joining a throng of regional credits that have tapped the markets on a jam-packed week.

The borrowers came after deals from a mix of Chinese and Hong Kong issuers, as well as a bond from an Indonesian property developer. This deluge of issuance was generally received well by investors. But when they were given the chance to expand their geographical exposure, they jumped at the chance.

The current market conditions have encouraged a variety of issuers to raise fresh funds or...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222